Literature DB >> 1923742

[The prestige of illnesses and medical specialties].

D Album1.   

Abstract

Diseases and medical specialties differ as regards social prestige. Samples of experienced physicians, medical students at two different levels, and other health professions were asked to rate 38 diseases and 22 medical specialties and subspecialties by prestige. The measured differences in prestige were substantial. Among the diseases, myocardial infarction, leukemia and brain tumour were ranked highest, whereas fibrositis, liver cirrhosis and depressive neurosis came lowest. Among the specialties, neurosurgery, cardiology and thorax surgery were top ranked, while geriatrics, dermatology and psychiatry had lowest prestige. The differences between the ratings of the doctors, medical students and representatives of other health professions were small. This result indicates that the resulting scales of prestige of diseases and specialties, besides being of interest in themselves, can be used for purposes of analysis, e.g. in analysis of the allocation of economic resources in the health services.

Entities:  

Mesh:

Year:  1991        PMID: 1923742

Source DB:  PubMed          Journal:  Nord Med        ISSN: 0029-1420


  2 in total

Review 1.  Fighting stigma of mental illness in midsize European countries.

Authors:  Alina Beldie; Johan A den Boer; Cecilia Brain; Eric Constant; Maria Luisa Figueira; Igor Filipcic; Benoît Gillain; Miro Jakovljevic; Marek Jarema; Daniela Jelenova; Oguz Karamustafalioglu; Blanka Kores Plesnicar; Andrea Kovacsova; Klara Latalova; Josef Marksteiner; Filipa Palha; Jan Pecenak; Jan Prasko; Dan Prelipceanu; Petter Andreas Ringen; Norman Sartorius; Erich Seifritz; Jaromir Svestka; Magdalena Tyszkowska; Johannes Wancata
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04       Impact factor: 4.328

2.  High turnover in clinical dietetics: a qualitative analysis.

Authors:  Sarah Hewko; Amirah Oyesegun; Samantha Clow; Charlene VanLeeuwen
Journal:  BMC Health Serv Res       Date:  2021-01-06       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.